C4 Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:CCCC) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -67.25 M-86.97 M-105.94 M-106.84 M-65.16 M-98.69 M -95.35 M Cash from investing activities -190.5 M-189.34 M58.42 M158.35 M-51.27 M-8.6 M -21.57 M Cash from financing activities 348.93 M171.4 M1.15 M45.49 M45.34 M126.4 M 126.91 M Free cash flow -67.25 M-86.97 M-105.94 M-106.84 M-65.16 M-99.3 M -96.02 M

News

Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?

C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Lags Revenue Estimates

LENZ Therapeutics, Inc. (LENZ) Reports Q1 Loss, Beats Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Lags Revenue Estimates

What's Going On With C4 Therapeutics Stock Thursday? - C4 Therapeutics (NASDAQ:CCCC)

Is C4 Therapeutics (CCCC) Stock Outpacing Its Medical Peers This Year?

Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice

Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?

Barclays raises C4 Therapeutics stock price target on trial progress

TD Cowen reiterates Buy rating on C4 Therapeutics stock

C4 earnings beat by $0.11, revenue topped estimates

Brookline Capital raises C4 Therapeutics stock price target on trial progress